However, we did not find correlations with inflammatory markers and levels were not significantly different between survivors and non-survivors, yet animal models showed that a substitution of recombinant human PLTP may improve sepsis outcomes (Deckert et al., 2017). This evidence concerns the gene PLTP and Sepsis.